Long-Term Iron Accumulation Strips Neurons of Disease Resilience

Summary: Neurodegenerative conditions like Alzheimer’s and Parkinson’s diseases afflict tens of millions of people worldwide, driven by a complex web of cellular vulnerabilities that scientists are actively racing to untangle. For years, an intriguing clue has hovered at the edges of neurodegeneration research: the gradual, progressive buildup of iron inside aging neurons. While this mineral accumulation appears harmless early in life, it eventually transforms into a catalyst for slow, widespread neuronal demise.

A breakthrough study finally unmasked the temporal mechanics behind this heavy-metal threat. By engineering the first-ever progressive cellular model of long-term iron accumulation, the team discovered that chronic iron exposure systematically dismantles a neuron’s internal defense systems over time. This chronic depletion leaves the cells fragile, defenseless, and highly vulnerable to secondary environmental stressors, a distinct, time-dependent degenerative pathway the researchers have named chronoferroptosis.

Key Facts

  • Introducing Chronoferroptosis: Chronoferroptosis adds the dimension of time to classical ferroptosis, proving that long-term iron exposure functions as a progressive, sub-lethal cellular stress pathway rather than a simple, rapid execution switch.
  • The Threshold of Resilience: The study demonstrates that iron itself is not an immediate cellular toxin; rather, its prolonged accumulation past a specific threshold strips neurons of their natural resilience, leaving them hyper-susceptible to age-related failure.
  • Lipid Peroxidation Escalation: Chronically exposed neurons displayed a severe escalation in lipid peroxidation, a destructive process akin to cellular fats turning rancid, alongside the systemic depletion of vital antioxidant defense proteins.
  • Acute vs. Chronic Disconnect: Neurons subjected to short-term, acute iron exposure (6 to 8 hours) easily handled secondary cellular insults, whereas neurons exposed chronically (9 days) suffered rapid catastrophic collapse when facing identical stressors.
  • The Export Machinery Failure: The Salk team suspects the underlying trigger for this progressive age-related buildup is a slow failure in the neuron’s specialized iron-export machinery, causing recycled iron to pool indefinitely inside the cell.
  • Therapeutic Resilience Boosters: Unlocking this temporal pathway opens a major therapeutic avenue. The Salk lab has already synthesized several promising chemical compounds specifically engineered to inhibit chronoferroptosis and preserve youthful neural resilience.

Source: Salk Institute

Neurodegenerative diseases affect tens of millions of people worldwide. Among these, Alzheimer’s and Parkinson’s diseases are the most common; in the United States alone, the Alzheimer’s Disease Association and Parkinson’s Foundation report roughly 7 million people with Alzheimer’s and another million with Parkinson’s. An intriguing clue lies in the tangled mystery of neurodegeneration that scientists are working to solve: iron accumulation.

Scientists have noticed that iron can slowly build up inside neurons. Early in life, this iron accumulation appears to have little effect on neuronal function. However, later in life, it can contribute to a slow neuronal demise. Salk Institute researchers studied nerve cells to figure out if and how this iron accumulation relates to neurodegenerative diseases.

They found that the excess iron stuck in neurons lowers the cells’ defenses, making them more vulnerable to stressors and other cellular insults through a process they named chronoferroptosis.

The study, published in Cell Death Discovery on June 18, 2026, points to iron accumulation as a key target in the effort to predict, prevent, and treat neurodegenerative diseases.

“Resilience has become a huge topic of discussion when it comes to Alzheimer’s disease and other neurodegenerative disorders, trying to make the brain more resilient in the face of stressors that contribute to neurodegeneration,” says senior and co-corresponding author Pam Maher, PhD, a research professor at Salk. “Our study reveals that cells lose resilience when iron hits a certain level, making neurons more susceptible to stressors that damage or even kill them.”

What do we already know about how the body uses iron, and is it linked to neurodegeneration?

Iron is an essential mineral for a healthy body. Found in dark leafy greens, starchy cereals, lean meats, seafood, and other common foods, iron helps red blood cells develop, carries oxygen around the body, makes hormones, and so much more, with a hand in everything from the immune system to energy production.

“It’s one of the most important minerals in the body,” says co-corresponding author Nawab John Dar, PhD, a postdoctoral researcher in Maher’s lab. “So, it isn’t the iron itself that is a problem with age. It is this accumulation of iron over time that is the problem.”

While the jury is still out on the exact mechanisms that initiate iron accumulation in neurons, the Salk team suspects the buildup is caused by a failure in the cells’ iron export machinery—iron enters neurons as usual but fails to get removed after use. But this failure doesn’t impact neurons for quite some time. The question is, why?

“People have been doing these experiments looking at iron exposure’s influence on cells over short 24- to 48-hour spans,” explains Dar. “But if neurodegenerative disorders are progressive, shouldn’t we have a cellular model that is progressive, too?”

Is iron accumulation making neurons less resilient?

Using a human-derived nerve cell line, the Salk team created the first progressive model of iron accumulation in neuronal cells. They compared the effects of both acute (between six and eight hours) and chronic (nine days) exposure to iron. What they discovered was an entirely new pathway, which they dubbed chronoferroptosis.

Maher has been studying ferroptosis for decades. Until now, ferroptosis was considered an iron-dependent cell death pathway, with cell death dependent on a process called lipid peroxidation. “It is like the cellular equivalent of when a cooking oil or nut goes bad. The fats in that oil or nut have undergone peroxidation,” explains Maher.

Chronoferroptosis adds the dimension of time to ferroptosis. To the researchers’ surprise, the pathway does not necessarily end in cell death. Instead, the findings reveal that ferroptosis can act as a cellular stress pathway.

In acutely exposed neurons, there was very little biochemical difference pre- and post-exposure to iron. However, in chronically exposed neurons, there were lots of changes: upregulation of some processes and downregulation of others; accumulation of harmful chemicals and depletion of helpful ones; and elevated lipid peroxidation. And when each exposure group was exposed to further stress, acutely exposed neurons could handle the stress, while chronically exposed neurons could not.

“We think these coordinated alterations in iron-handling and antioxidant defense proteins make chronically exposed neurons vulnerable to neurodegenerative pathology,” says Dar. “Entering this state of chronoferroptosis may set neurons up for age-related failure.”

How might chronoferroptosis inform neurodegeneration care?

By creating the first progressive model of iron accumulation in neuronal cells, the researchers were able to reveal surprising new clues in the case to crack neurodegeneration. “It’s not the amount of iron that seals the fate of these cells,” says Dar, “it’s the amount of time they spend under stress.”

Perhaps scientists will one day be able to detect when the brain begins entering this vulnerable state, when iron accumulation starts stressing neurons. They could then develop new interventions to address iron imbalances and keep neurons more resilient for longer.

“It’s not something we worked on in this paper, but our lab has developed several compounds to inhibit this pathway,” says Maher. “This could really be a promising therapeutic route for boosting neuron resilience and staving off neurodegeneration as we grow older.”

Other authors and funding

The paper was also coauthored by David Soriano-Castell of Salk.

The work was supported by the National Institutes of Health (R01AG067331, R01AG069206).

Key Questions Answered:

Q: If iron is an essential mineral for a healthy body, why does it become dangerous to neurons over time?

A: Iron is absolutely vital for fundamental biological tasks, from carrying oxygen in red blood cells to fueling energy production inside mitochondria. The mineral itself isn’t a toxin. The issue is a failure of cellular logistics as we get older. While young neurons efficiently bring in iron, use it, and export the excess, aging neurons suffer from a gradual breakdown in their iron-export machinery. The iron gets trapped. It isn’t the presence of the iron that seals a neuron’s fate, but the sheer amount of time the cell spends under the low-grade stress of this compounding chemical imbalance.

Q: How does chronoferroptosis differ from the standard concept of ferroptosis that scientists already knew about?

A: Standard ferroptosis is traditionally viewed as a fast, binary cell-death pathway—essentially a rapid cellular suicide triggered by iron-dependent lipid peroxidation (where the fats inside the cell membrane go “rancid”). Chronoferroptosis adds the critical dimension of time, mirroring the slow progression of actual neurodegenerative diseases. Salk researchers discovered that long-term, low-dose iron accumulation doesn’t immediately kill the cell. Instead, it acts as a prolonged, insidious stress pathway that quietly dismantles the cell’s antioxidant shield. It doesn’t drop the guillotine; it simply strips the neuron of its armor.

Q: What door does this discovery open for future Alzheimer’s and Parkinson’s disease treatments?

A: For years, clinical trials targeting late-stage neurodegeneration have failed because they try to save neurons that are already dead or dying. Chronoferroptosis gives science an upstream, preventative target. If clinicians can identify when aging brains begin transitioning into this fragile, iron-stressed state, they can intervene decades before significant cognitive decline sets in. Furthermore, Dr. Pam Maher’s lab has already developed several novel chemical compounds designed to block this exact pathway, paving the way for neuroprotective drugs that preserve a neuron’s baseline resilience and stave off age-related failure.

Editorial Notes:

  • This article was edited by a Neuroscience News editor.
  • Journal paper reviewed in full.
  • Additional context added by our staff.

About this neuroscience research news

Author: Salk Communications
Source: 
Salk Institute
Contact: Salk Communications – Salk Institute
Image: The image is credited to Neuroscience News

Original Research: Open access.
Sustained dysregulation of iron and glutathione homeostasis induces chronoferroptosis, a persistent ferroptotic adaptation in neuronal cells” by Nawab John Dar, David Soriano-Castell & Pamela Maher. Cell Death Discovery
DOI:10.1038/s41420-026-03208-6


Abstract

Sustained dysregulation of iron and glutathione homeostasis induces chronoferroptosis, a persistent ferroptotic adaptation in neuronal cells

Although iron accumulates in brain regions impacted by neurodegenerative diseases such as Alzheimer’s and Parkinson’s, how chronic elevated iron levels contribute to neuronal dysfunction remains unclear. Here, we show that sustained iron overload, but not acute exposure, leads to a state of ferroptotic stress where nerve cells remain viable but become hypersensitive to oxidative injury.

Retinoic acid-differentiated SH-SY5Y neuronal cells were exposed to acute (6–8 h) or chronic (9 days) iron loading to model transient versus prolonged age-related iron stress. While acute iron exposure produced minimal biochemical changes and did not sensitize cells to oxidative or ferroptotic challenges, chronic iron exposure induced ferritin upregulation, mitochondrial superoxide accumulation, suppression of GPX4 expression, elevated lipid peroxidation and loss of cellular glutathione (GSH).

In addition, chronic but not acute GSH depletion by buthionine sulfoximine (BSO) recapitulated the iron-induced phenotype. Cells under chronic ferroptotic stress exhibited increased sensitivity not only to the ferroptosis inducer RSL-3 but also to hydrogen peroxide. Ferrostatin-1 significantly mitigated these effects suggesting that lipid peroxidation drives this state.

Together, these findings demonstrate that, in contrast with acute exposure, chronic disruption of iron homeostasis with consequent GSH depletion remodels cellular redox homeostasis over time, inducing a state we term chronoferroptosis: a persistent ferroptotic adaptation characterized by coordinated alterations in iron-handling and antioxidant defense proteins that may represent early vulnerability to neurodegenerative pathology.

Thus, these studies highlight the importance of sustained stress paradigms for modeling the progressive nature of neurodegenerative diseases.